# Akebia Therapeutics, Inc.: Form 8-K, filed Oct 14, 2026

- Company: [Akebia Therapeutics, Inc.](/companies/akba.md) (CIK 1517022)
- Form: 8-K
- Filed: 2026-10-14
- Accepted by EDGAR: Oct 14, 2026, 07:57 ET
- Period: 2026-10-07
- Accession: 0001517022-26-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1517022/000151702226000071/akba-20261007.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517022/000151702226000071/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517022/000151702226000071/akba-20261007.htm

Filed Oct 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001517022-26-000071. Last ingested by Listed: Nov 5, 2026, 12:07 ET. No prices; not investment advice.
